BLA Filing Meeting Memo - CINRYZE

Filing Meeting Summary

Date: September 13, 2007           

Time: 10:30 AM

From: Nannette Cagungun

To: STN 125267/0

Re: Filing Meeting for LevPharma’s C1 Esterase Inhibitor BLA

________________________________________________________________________

CBER Participants:

Nannette Cagungun
 Paul Buehler
 Omer Butt
 Felice D’Agnillo
 Dave Doleski - Absent
 Mahmood Farshid – Absent
 Iftekhar Mahmood
 Elena Karnaukhova - Absent
 Charles Maplethorpe
 Jean Mackie
 Robert Wesley - Absent
 Boris Zaslavsky -

Discussion:

The review committee members recommended that the BLA be filed with the exception of the clinical reviewer who expressed some concerns regarding the filing suitability of the application. His recommendations will be presented to the acting division director.

BIMO and DMPQ reviwers will be contacted to determine if inspection plans have been made. Joseph Quander will also be contacted regarding specifics on lot release.

Post Meeting Note: A decision was reached in consultation with the acting division director to file the BLA application. A Filing Letter will be issued on or before the action due date of 28 September 2007.
